Search hospitals > New York > Auburn
Hematology Oncology Associates of Central New York-Auburn
Claim this profileAuburn, New York 13021
Global Leader in Breast Cancer
Global Leader in Parotid Gland Cancer
Conducts research for Breast cancer
Conducts research for Lung Cancer
Conducts research for Cancer
50 reported clinical trials
2 medical researchers
Summary
Hematology Oncology Associates of Central New York-Auburn is a medical facility located in Auburn, New York. This center is recognized for care of Breast Cancer, Parotid Gland Cancer, Breast cancer, Lung Cancer, Cancer and other specialties. Hematology Oncology Associates of Central New York-Auburn is involved with conducting 50 clinical trials across 99 conditions. There are 2 research doctors associated with this hospital, such as Jeffrey J. Kirshner and Steven M. Duffy.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 positive
PR positive
2Parotid Gland Cancer
Global LeaderStage IV
Stage III
HER2 positive
Top PIs
Jeffrey J. KirshnerHematology Oncology Associates of Central New York-East Syracuse6 years of reported clinical research
Studies Parotid Gland Cancer
Studies Lung Cancer
26 reported clinical trials
50 drugs studied
Steven M. DuffyHematology Oncology Associates of Central New York-East Syracuse5 years of reported clinical research
Studies Parotid Gland Cancer
Studies Breast Cancer
19 reported clinical trials
38 drugs studied
Clinical Trials running at Hematology Oncology Associates of Central New York-Auburn
Breast Cancer
Lung Cancer
Breast cancer
Multiple Myeloma
Parotid Gland Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
ALK Gene Rearrangement
Lymphoma
Chronic Lymphocytic Leukemia
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Cognitive Training
for Breast Cancer Survivors
This Phase III trial will examine the efficacy of computerized cognitive training methods on perceived cognitive impairment in breast cancer survivors.
Recruiting1 award N/A5 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Hematology Oncology Associates of Central New York-Auburn?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.